| scholarly article | Q13442814 |
| P2093 | author name string | Kiven Erique Lukong | |
| P2860 | cites work | One hundred years of hormones | Q24539078 |
| Ancient Greek and Greco-Roman methods in modern surgical treatment of cancer | Q24648677 | ||
| BRCA1 and BRCA2 mutations in Scotland and Northern Ireland | Q24650826 | ||
| Tamoxifen Resistance: Emerging Molecular Targets | Q26739969 | ||
| The fate of chemoresistance in triple negative breast cancer (TNBC) | Q26775232 | ||
| Broad targeting of angiogenesis for cancer prevention and therapy | Q27002903 | ||
| Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA | Q27011221 | ||
| Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss | Q27322590 | ||
| Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer | Q27853134 | ||
| Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene | Q27860693 | ||
| Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Molecular portraits of human breast tumours | Q28032461 | ||
| A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
| A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition | Q28305715 | ||
| The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups | Q29614700 | ||
| Identification of the breast cancer susceptibility gene BRCA2 | Q29616290 | ||
| Who discovered the lymphatic system | Q30429537 | ||
| Current strategies for the prevention of breast cancer | Q33599463 | ||
| Estrogen action: a historic perspective on the implications of considering alternative approaches | Q33709986 | ||
| No shrinking violet: Rose Kushner and the rise of American breast cancer activism | Q33728940 | ||
| The Epidemiology of Male Breast Cancer | Q38676450 | ||
| On the myth of the Edwin Smith papyrus: is it magic or science? | Q38920291 | ||
| Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer. | Q39021766 | ||
| Molecular alterations in triple-negative breast cancer-the road to new treatment strategies | Q39034845 | ||
| Exosomes and breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to treatment | Q39041040 | ||
| Commentary on the significance for modern neurology of the 17th century B.C. Surgical Papyrus | Q39062966 | ||
| Hormone Receptors: Studies on the Interaction of Estrogen with the Uterus | Q39977967 | ||
| International Variation in Female Breast Cancer Incidence and Mortality Rates. | Q40550522 | ||
| Franciscus de le Boë or Sylvius 1614-72 | Q41381121 | ||
| Wilhelm Conrad Röentgen (1845-1923), the discovery of x rays and perinatal diagnosis | Q43097267 | ||
| The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. | Q43974233 | ||
| Risk factors for breast cancer: a reanalysis of two case-control studies from 1926 and 1931. | Q44115162 | ||
| The evolution of mammography | Q46064646 | ||
| History of surgery for breast cancer: radical to the sublime | Q47354788 | ||
| Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor | Q48369441 | ||
| Ado-trastuzumab Emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancer. | Q54342129 | ||
| Exposure-response relationship of T-DM1: insight into dose optimization for patients with HER2-positive metastatic breast cancer. | Q54380348 | ||
| Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. | Q54516956 | ||
| On Oophorectomy in the Treatment of Cancer | Q55416068 | ||
| Aromatase, aromatase inhibitors, and breast cancer | Q57137315 | ||
| The evolution of paradigms for the management of breast cancer: a personal perspective | Q68100328 | ||
| Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation | Q69884400 | ||
| Gene expression profiling of breast cancer | Q79709460 | ||
| Gene expression profiling in breast cancer | Q81375651 | ||
| The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer | Q83760986 | ||
| Risk factors. Oncotype DX assay predicts local recurrence in breast cancer | Q84361962 | ||
| Targeting a Long Noncoding RNA in Breast Cancer | Q87616370 | ||
| New selective estrogen and androgen receptor modulators | Q33814078 | ||
| Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. | Q33827808 | ||
| History of mammography | Q33857426 | ||
| Selective estrogen receptor modulators (SERMs) in clinical practice | Q33872604 | ||
| Similarities and distinctions in the mode of action of different classes of antioestrogens | Q33917000 | ||
| Tumorigenicity of hypoxic respiring cancer cells revealed by a hypoxia-cell cycle dual reporter | Q34119948 | ||
| Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality | Q34135443 | ||
| Deconstructing the molecular portraits of breast cancer | Q34154147 | ||
| Tamoxifen: a most unlikely pioneering medicine | Q34180688 | ||
| Epidermal Growth Factor | Q34192014 | ||
| Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer | Q34193309 | ||
| BRCA1 and BRCA2: 1994 and beyond | Q34345297 | ||
| Bernardino Ramazzini: the father of occupational medicine | Q34358333 | ||
| Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene | Q34560337 | ||
| The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services | Q35000282 | ||
| Mammography: a history of success and scientific enthusiasm | Q35109772 | ||
| The History of Breast Cancer Advocacy | Q35114117 | ||
| Estrogen metabolism and breast cancer | Q35861660 | ||
| Breast cancer classification and prognosis based on gene expression profiles from a population-based study | Q35918291 | ||
| Oncotype DX Test Offers Guidance For Women Debating Chemotherapy | Q36606328 | ||
| Franciscus Sylvius (1614-1672): a historical review | Q36649737 | ||
| Triple-negative/basal-like breast cancer: review | Q37352934 | ||
| Triple-negative breast cancer--current status and future directions | Q37630082 | ||
| Iniparib, a PARP1 inhibitor for the potential treatment of cancer, including triple-negative breast cancer | Q37783573 | ||
| Bloody nipple discharge is a predictor of breast cancer risk: a meta-analysis | Q37938828 | ||
| Emerging targeted therapies in triple-negative breast cancer | Q38046585 | ||
| Breastfeeding and the prevention of breast cancer: a retrospective review of clinical histories. | Q38128355 | ||
| Molecular testing in breast cancer. | Q38178297 | ||
| Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches | Q38198444 | ||
| Cancer stem cells and their implication in breast cancer. | Q38207159 | ||
| Targeting HER2 for the treatment of breast cancer | Q38317974 | ||
| Breast cancer genes: looking for BRACA's lost brother | Q38335612 | ||
| Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature. | Q38575914 | ||
| Percutaneous Image-Guided Cryoablation of Breast Cancer: A Systematic Review. | Q38581506 | ||
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 64-77 | |
| P577 | publication date | 2017-01-27 | |
| P1433 | published in | BBA clinical | Q27725665 |
| P1476 | title | Understanding breast cancer - The long and winding road | |
| P478 | volume | 7 |
| Q89976152 | Activation of JNK and p38 in MCF-7 Cells and the In Vitro Anticancer Activity of Alnus hirsuta Extract |
| Q49693736 | Anti-Tumor and Radiosensitization Effects of N-Butylidenephthalide on Human Breast Cancer Cells |
| Q47097941 | Aptamer selection and applications for breast cancer diagnostics and therapy |
| Q89633366 | Autotaxin and Breast Cancer: Towards Overcoming Treatment Barriers and Sequelae |
| Q48292951 | Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants |
| Q96817189 | Co-expression based cancer staging and application |
| Q58730323 | Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines |
| Q55262345 | Diagnostic Accuracy of Digital Mammography in the Detection of Breast Cancer. |
| Q94570608 | Distribution and characteristics of androgen receptor (AR) in breast cancer among women in Addis Ababa, Ethiopia: A cross sectional study |
| Q89730990 | Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT |
| Q92376678 | Encapsulation of Thermo-Sensitive Lauric Acid in Silica Shell: A Green Derivate for Chemo-Thermal Therapy in Breast Cancer Cell |
| Q58554049 | Estrogen alpha receptor antagonists for the treatment of breast cancer: a review |
| Q58614201 | Hydroalcoholic Extract of Levisticum officinale Increases cGMP Signaling Pathway by Down-Regulating PDE5 Expression and Induction of Apoptosis in MCF-7 and MDA-MB-468 Breast Cancer Cell Lines |
| Q92577404 | Involvement of the P2X7 receptor in the migration and metastasis of tamoxifen-resistant breast cancer: effects on small extracellular vesicles production |
| Q39254523 | Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells. |
| Q58725398 | Long noncoding RNA ROR promotes breast cancer by regulating the TGF-β pathway |
| Q50523894 | PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer. |
| Q61796811 | Polymorphism of DNA repair genes in breast cancer |
| Q98612881 | Polymorphism of XRCC3 in Egyptian Breast Cancer Patients |
| Q41661268 | Potential Diagnostic and Therapeutic Applications of Oligonucleotide Aptamers in Breast Cancer |
| Q64957263 | Potential use of Pichia pastoris strain SMD1168H expressing DNA topoisomerase I in the screening of potential anti‑breast cancer agents. |
| Q99207533 | Prodigiosin/PU-H71 as a novel potential combined therapy for triple negative breast cancer (TNBC): preclinical insights |
| Q44670997 | Screening Novel Molecular Targets of Metformin in Breast Cancer by Proteomic Approach |
| Q91975517 | The Effect of Health Literacy Counselling on Self-Care in Women after Mastectomy: a Randomized Clinical Trial |
| Q43375967 | The Predictive Value of PITX2 DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges |
| Q49974944 | The mTOR inhibitor AZD8055 overcomes tamoxifen resistance in breast cancer cells by down-regulating HSPB8. |
| Q47179544 | The regulatory roles of long non-coding RNAs in the development of chemoresistance in breast cancer |
Search more.